**Core Concept**
Malignant hyperthermia is a rare but life-threatening medical emergency that occurs in response to certain anesthetics and muscle relaxants. It is characterized by an uncontrolled rise in body temperature, muscle rigidity, and metabolic acidosis.

**Why the Correct Answer is Right**
Malignant hyperthermia is triggered by the activation of the ryanodine receptor type 1 (RyR1) on skeletal muscle cells, leading to an abnormal release of calcium ions. This causes an uncontrolled increase in muscle contraction and heat production. The anesthetics halothane and succinylcholine, as well as the muscle relaxant d-tubocurarine, are known to trigger malignant hyperthermia by interacting with the RyR1 receptor.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because malignant hyperthermia is not caused by a deficiency in parathyroid hormone (PTH), which regulates calcium levels in the body.
**Option B:** This option is incorrect because malignant hyperthermia is not caused by an overdose of insulin, which regulates blood sugar levels.
**Option C:** This option is incorrect because malignant hyperthermia is not caused by an allergic reaction to an anesthetic, although some anesthetics may cause allergic reactions.

**Clinical Pearl / High-Yield Fact**
Thehalothane and succinylcholine are known to trigger malignant hyperthermia in susceptible individuals, and patients with a family history of the disorder should be screened for the genetic mutation before undergoing general anesthesia.

**Correct Answer:** C.